M&G PLC Hutchmed (China) LTD Transaction History
M&G PLC
- $17.1 Billion
- Q3 2025
A detailed history of M&G PLC transactions in Hutchmed (China) LTD stock. As of the latest transaction made, M&G PLC holds 204,432 shares of HCM stock, worth $3.08 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
204,432
Previous 259,617
21.26%
Holding current value
$3.08 Million
Previous $3.91 Million
17.61%
% of portfolio
0.02%
Previous 0.02%
Shares
4 transactions
Others Institutions Holding HCM
# of Institutions
57Shares Held
5.74MCall Options Held
0Put Options Held
0-
Schroder Investment Management Group London, X02.47MShares$37.2 Million0.03% of portfolio
-
Allianz Asset Management Gmb H Munich, 2M909KShares$13.7 Million0.02% of portfolio
-
Jane Street Group, LLC New York, NY340KShares$5.13 Million0.0% of portfolio
-
State Street Corp Boston, MA318KShares$4.79 Million0.0% of portfolio
-
Aia Group LTD Hong Kong, K3315KShares$4.76 Million0.11% of portfolio
About HUTCHMED (China) Ltd
- Ticker HCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 172,955,008
- Market Cap $2.61B
- Description
- HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...